|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Asset impairments and exit costs | |||||
| Gain on divestitures and acquisition | |||||
| Amortization of intangible assets | |||||
| Operating income | |||||
| Benefit plan non-service (expense)/income | |||||
| Interest and other expense, net | |||||
| Gain on marketable securities | |||||
| Earnings before income taxes | |||||
| Income tax provision | |||||
| Gain/(loss) on equity method investment transactions | |||||
| Equity method investment net earnings | |||||
| Net earnings | |||||
| less: Noncontrolling interest earnings | |||||
| Net earnings attributable to Mondelēz International | |||||
| Per share data: | |||||
| Basic earnings per share attributable to Mondelēz International (in dollars per share) | |||||
| Diluted earnings per share attributable to Mondelēz International (in dollars per share) |
Loading...